Faysal M H
Urology. 1980 Jul;16(1):23-6. doi: 10.1016/0090-4295(80)90325-8.
Data on a selected group of 90 male patients who had total cystectomy for diffuse transitional cell carcinoma encroaching on the bladder neck and/or involving the prostatic urethra were studied in relation to the incidence of urethral involvement. Of the 59 patients who had only total cystectomy, 8 (13.5%) required a subsequent therapeutic urethrectomy for clinical anterior urethral carcinoma. Of the remaining 31 patients who underwent simultaneous prophylactic urethrectomy at the time of cystectomy, 2 (6.4%) had transitional cell carcinoma and 1 had moderate mucosal atypia of the anterior urethra. Although the remaining urethra constitutes a potential hazard for further tumor formation, only 1 of 10 patients with urethral carcinoma possibly died of urethral tumor recurrence. Therefore, the urologist has a choice either to follow the patient closely with cytologic urethral wash or to do a prophylactic urethrectomy, especially in patients who are difficult to follow-up closely.
对一组选定的90例男性患者进行了研究,这些患者因弥漫性移行细胞癌侵犯膀胱颈和/或累及前列腺尿道而接受了全膀胱切除术,并分析了尿道受累的发生率。在仅接受全膀胱切除术的59例患者中,有8例(13.5%)因临床前尿道癌需要随后进行治疗性尿道切除术。在其余31例在膀胱切除术时同时进行预防性尿道切除术的患者中,2例(6.4%)患有移行细胞癌,1例前尿道有中度黏膜异型增生。尽管剩余的尿道构成了进一步肿瘤形成的潜在风险,但10例尿道癌患者中只有1例可能死于尿道肿瘤复发。因此,泌尿外科医生可以选择对患者进行密切的尿道细胞学冲洗随访,或者进行预防性尿道切除术,尤其是对于难以密切随访的患者。